Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35

作者: Menglin Zhao , Jiaxian Wang , Manyu Luo , Han Luo , Meiqi Zhao

DOI: 10.1007/S00253-018-9021-6

关键词:

摘要: Chinese hamster ovary (CHO) cells are the most widely used mammalian hosts for recombinant protein production. However, by conventional random integration strategy, development of a high-expressing and stable CHO cell line has always been difficult task due to heterogenic insertion its caused requirement multiple rounds selection. Site-specific transgenes into hot spots is an ideal strategy overcome these challenges since it can generate isogenic lines with consistent productivity stability. In this study, we investigated three sites potential high transcriptional activities: C12orf35, HPRT, GRIK1, determine possible in cells, further construct reliable site-specific develop efficiently. Genes encoding representative proteins mCherry anti-PD1 monoclonal antibody were targeted loci respectively through CRISPR/Cas9 technology. Stable generated successfully after single round comparison control, all showed higher productivity, among which C12orf35 locus was advantageous both Binding affinity N-glycan analysis revealed that batches product similar quality independent on integrated sites. Deep sequencing demonstrated there low level off-target mutations CRISPR/Cas9, but none them contributed process transgene lines. Our results feasibility as target site exogenous gene integration, strongly suggested mediated rapid

参考文章(36)
Tao Sun, Chaodong Li, Lei Han, Hua Jiang, Yueqing Xie, Baohong Zhang, Xiuping Qian, Huili Lu, Jianwei Zhu, Functional knockout of FUT8 in Chinese hamster ovary cells using CRISPR/Cas9 to produce a defucosylated antibody Engineering in Life Sciences. ,vol. 15, pp. 660- 666 ,(2015) , 10.1002/ELSC.201400218
Simon Fischer, René Handrick, Kerstin Otte, The art of CHO cell engineering: A comprehensive retrospect and future perspectives Biotechnology Advances. ,vol. 33, pp. 1878- 1896 ,(2015) , 10.1016/J.BIOTECHADV.2015.10.015
Miguel A Moreno-Mateos, Charles E Vejnar, Jean-Denis Beaudoin, Juan P Fernandez, Emily K Mis, Mustafa K Khokha, Antonio J Giraldez, CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo Nature Methods. ,vol. 12, pp. 982- 988 ,(2015) , 10.1038/NMETH.3543
Ravichandra Bachu, Iñigo Bergareche, Lawrence A. Chasin, CRISPR‐Cas targeted plasmid integration into mammalian cells via non‐homologous end joining Biotechnology and Bioengineering. ,vol. 112, pp. 2154- 2162 ,(2015) , 10.1002/BIT.25629
Tetsushi Sakuma, Mitsumasa Takenaga, Yoshinori Kawabe, Takahiro Nakamura, Masamichi Kamihira, Takashi Yamamoto, None, Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids International Journal of Molecular Sciences. ,vol. 16, pp. 23849- 23866 ,(2015) , 10.3390/IJMS161023849
Jianwei Zhu, Mammalian cell protein expression for biopharmaceutical production Biotechnology Advances. ,vol. 30, pp. 1158- 1170 ,(2012) , 10.1016/J.BIOTECHADV.2011.08.022
Prashant Mali, John Aach, P Benjamin Stranges, Kevin M Esvelt, Mark Moosburner, Sriram Kosuri, Luhan Yang, George M Church, CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nature Biotechnology. ,vol. 31, pp. 833- 838 ,(2013) , 10.1038/NBT.2675
Jae Seong Lee, Thomas Beuchert Kallehauge, Lasse Ebdrup Pedersen, Helene Faustrup Kildegaard, Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway Scientific Reports. ,vol. 5, pp. 8572- 8572 ,(2015) , 10.1038/SREP08572
L. Cong, F. A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P. D. Hsu, X. Wu, W. Jiang, L. A. Marraffini, F. Zhang, Multiplex Genome Engineering Using CRISPR/Cas Systems Science. ,vol. 339, pp. 819- 823 ,(2013) , 10.1126/SCIENCE.1231143
Hamid Reza Jabalameli, Hamid Zahednasab, Amin Karimi-Moghaddam, Mohammad Reza Jabalameli, Zinc finger nuclease technology: Advances and obstacles in modelling and treating genetic disorders Gene. ,vol. 558, pp. 1- 5 ,(2015) , 10.1016/J.GENE.2014.12.044